Potential Inhibitors for Novel Coronavirus Protease Identified by Virtual Screening of 606 Million Compounds

The rapid outbreak of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in China followed by its spread around the world poses a serious global concern for public health. To this date, no specific drugs or vaccines are available to treat SARS-CoV-2 despite its close relation to...

Descripción completa

Detalles Bibliográficos
Autores principales: Fischer, André, Sellner, Manuel, Neranjan, Santhosh, Smieško, Martin, Lill, Markus A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7279339/
https://www.ncbi.nlm.nih.gov/pubmed/32455534
http://dx.doi.org/10.3390/ijms21103626

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7279339/
https://www.ncbi.nlm.nih.gov/pubmed/32455534
http://dx.doi.org/10.3390/ijms21103626

Ejemplares similares